Anti-Mycobacterial Activity of Flavonoid and Pyrimidine Compounds.


Journal

Molecules (Basel, Switzerland)
ISSN: 1420-3049
Titre abrégé: Molecules
Pays: Switzerland
ID NLM: 100964009

Informations de publication

Date de publication:
09 Oct 2022
Historique:
received: 05 08 2022
revised: 30 09 2022
accepted: 02 10 2022
entrez: 14 10 2022
pubmed: 15 10 2022
medline: 18 10 2022
Statut: epublish

Résumé

We evaluated the anti-mycobacterial effect of a flavonoid 5,7-dihydroxy-2-(4-hydroxyphenyl) 4

Identifiants

pubmed: 36235249
pii: molecules27196714
doi: 10.3390/molecules27196714
pmc: PMC9572476
pii:
doi:

Substances chimiques

Antitubercular Agents 0
Drug Combinations 0
Flavonoids 0
Pyrimidines 0
Cycloserine 95IK5KI84Z
Clarithromycin H1250JIK0A
Isoniazid V83O1VOZ8L
Rifampin VJT6J7R4TR

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Subventions

Organisme : CIHR
ID : 148606 ( RES0030971)
Pays : Canada

Déclaration de conflit d'intérêts

The authors declare no conflict of interest. The funders had no role in the design of the study; in the collection, analyses, or interpretation of data; in the writing of the manuscript, or in the decision to publish the results.

Références

Antimicrob Agents Chemother. 1997 May;41(5):992-8
pubmed: 9145858
J Infect Dis. 1991 Jun;163(6):1326-35
pubmed: 2037799
Curr Opin Chem Biol. 2002 Jun;6(3):367-74
pubmed: 12023118
J Am Chem Soc. 2001 May 9;123(18):4107-18
pubmed: 11457173
Cell. 2001 Mar 23;104(6):901-12
pubmed: 11290327
Curr Opin HIV AIDS. 2018 Nov;13(6):486-491
pubmed: 30080683
Sci Rep. 2020 May 18;10(1):8159
pubmed: 32424333
Antimicrob Agents Chemother. 1995 Jul;39(7):1542-5
pubmed: 7492101
Arch Biochem Biophys. 2018 Jan 1;637:9-20
pubmed: 29162368
Trop Med Int Health. 2004 Jan;9(1):25-40
pubmed: 14728604
Biochim Biophys Acta. 1993 Apr 8;1147(1):132-6
pubmed: 8466924
J Med Chem. 2007 Sep 20;50(19):4766-74
pubmed: 17696514
Cancers (Basel). 2018 Dec 28;11(1):
pubmed: 30597838
Infect Chemother. 2013 Dec;45(4):367-74
pubmed: 24475350
J Med Chem. 2005 Nov 3;48(22):7012-7
pubmed: 16250660
Int J Tuberc Lung Dis. 2012 Jun;16(6):724-32
pubmed: 22613684
Bioorg Med Chem. 2005 Dec 15;13(24):6663-71
pubmed: 16140016
Am Rev Respir Dis. 1989 Sep;140(3):634-7
pubmed: 2675703
Biochem Biophys Res Commun. 2003 Jun 27;306(2):530-6
pubmed: 12804597
Am J Respir Crit Care Med. 1996 Jun;153(6 Pt 1):1766-72
pubmed: 8665032
Infect Genet Evol. 2016 Nov;45:474-492
pubmed: 27612406
Curr Med Chem. 2005;12(16):1873-86
pubmed: 16101507
Curr Med Chem. 2015;22(1):132-49
pubmed: 25245513
Eur Respir Rev. 2019 May 29;28(152):
pubmed: 31142549
Nat Rev Drug Discov. 2013 May;12(5):388-404
pubmed: 23629506
Int J Tuberc Lung Dis. 2006 Aug;10(8):829-37
pubmed: 16898365
Int J Antimicrob Agents. 2008 Nov;32(5):421-6
pubmed: 18774266
Bioorg Med Chem. 2008 Nov 15;16(22):9790-4
pubmed: 18951808
Bioorg Med Chem. 2016 Nov 1;24(21):5521-5533
pubmed: 27665179
Clin Microbiol Rev. 1993 Jul;6(3):266-310
pubmed: 8358707
J Antimicrob Chemother. 2018 May 1;73(5):1138-1151
pubmed: 29360989
Chembiochem. 2002 Jan 4;3(1):108-10
pubmed: 17590962
Int J Mol Med. 2018 Jul;42(1):658-664
pubmed: 29620152
Microbiol Spectr. 2017 Mar;5(2):
pubmed: 28361737
Acta Leprol. 1989;7 Suppl 1:189-94
pubmed: 2503988
Thorax. 2013 Mar;68(3):283-7
pubmed: 23321600
Free Radic Biol Med. 1999 Jan;26(1-2):107-16
pubmed: 9890646
J Med Chem. 2003 Aug 28;46(18):3811-21
pubmed: 12930144
Nature. 1998 Jun 11;393(6685):537-44
pubmed: 9634230
Sci Rep. 2017 Jan 19;7:40752
pubmed: 28102344
Lancet Infect Dis. 2010 Sep;10(9):621-9
pubmed: 20797644
Front Microbiol. 2019 May 22;10:952
pubmed: 31191461
Cold Spring Harb Perspect Med. 2015 Apr 27;5(9):a017863
pubmed: 25918181
Front Pharmacol. 2017 Apr 20;8:158
pubmed: 28473769
Arch Virol. 2017 Sep;162(9):2539-2551
pubmed: 28547385
Cancer Res. 2010 Jan 15;70(2):440-6
pubmed: 20068163
Biomed Pharmacother. 2021 Aug;140:111596
pubmed: 34126315
Adv Med Sci. 2016 Mar;61(1):63-71
pubmed: 26521205
Diagn Microbiol Infect Dis. 2017 Jun;88(2):125-137
pubmed: 28291631
Chin J Nat Med. 2017 May;15(5):321-329
pubmed: 28558867
Semin Respir Crit Care Med. 2018 Jun;39(3):297-309
pubmed: 30071545
Curr Respir Med Rev. 2013 Jun 1;9(3):200-210
pubmed: 24683386
Nat Rev Genet. 2014 May;15(5):307-20
pubmed: 24662221
Int J Antimicrob Agents. 2005 Nov;26(5):343-56
pubmed: 16323269
Expert Rev Anticancer Ther. 2003 Oct;3(5):717-28
pubmed: 14599094
Antimicrob Agents Chemother. 2018 Feb 23;62(3):
pubmed: 29311070
J HIV Ther. 2002 Feb;7(1):13-6
pubmed: 11956499

Auteurs

Saurabh Garg (S)

Department of Surgery, Ray Rajotte Surgical-Medical Research Institute, Alberta Diabetes, and Transplant Institutes, Faculty of Medicine and Dentistry, College of Health Sciences, University of Alberta, Edmonton, AB T6G 0X0, Canada.

Rakesh Kumar (R)

ImMed Biotechnologies, Edmonton, AB T6R 2E8, Canada.

Dennis Kunimoto (D)

Department of Medicine, Faculty of Medicine and Dentistry, College of Health Sciences, University of Alberta, Edmonton, AB T6G 2R7, Canada.

Gina R Rayat (GR)

Department of Surgery, Ray Rajotte Surgical-Medical Research Institute, Alberta Diabetes, and Transplant Institutes, Faculty of Medicine and Dentistry, College of Health Sciences, University of Alberta, Edmonton, AB T6G 0X0, Canada.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH